Yarbrough Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $921K | Hold |
11,100
| – | – | 0.03% | 100 |
|
|
2025
Q1 | $900K | Sell |
11,100
-26,240
| -70% | -$2.13M | 0.04% | 99 |
|
|
2024
Q4 | $3.36M | Hold |
37,340
| – | – | 0.13% | 62 |
|
|
2024
Q3 | $3.69M | Hold |
37,340
| – | – | 0.15% | 59 |
|
|
2024
Q2 | $3.46M | Hold |
37,340
| – | – | 0.14% | 57 |
|
|
2024
Q1 | $3.54M | Hold |
37,340
| – | – | 0.15% | 59 |
|
|
2023
Q4 | $3.33M | Hold |
37,340
| – | – | 0.17% | 61 |
|
|
2023
Q3 | $2.73M | Hold |
37,340
| – | – | 0.16% | 63 |
|
|
2023
Q2 | $3.11M | Hold |
37,340
| – | – | 0.18% | 65 |
|
|
2023
Q1 | $2.85M | Buy |
37,340
+13,200
| +55% | +$1.01M | 0.23% | 65 |
|
|
2022
Q4 | $2M | Buy |
24,140
+13,030
| +117% | +$1.08M | 0.16% | 64 |
|
|
2022
Q3 | $881K | Hold |
11,110
| – | – | 0.07% | 89 |
|
|
2022
Q2 | $825K | Buy |
+11,110
| New | +$825K | 0.06% | 86 |
|